Lung Capacity and Your Genetics

Lung capacity refers to the maximum volume of air the lungs can hold, and research shows that a meaningful proportion of population variation in this measure is explained by inherited genetic factors. Spirometry studies—which measure lung volumes including forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)—have been used in large-scale genome-wide association studies (GWAS) to map the genetic landscape of respiratory function. This page summarizes what these studies have found and what a genetic tendency toward higher or lower lung capacity means in practice.

What is lung capacity?

Lung capacity encompasses several related measures of pulmonary volume. Total lung capacity (TLC) is the total air volume at maximum inhalation. Forced vital capacity (FVC) measures the maximum volume exhaled after a full inhalation, while FEV1 captures how much air can be exhaled in one second. In population and clinical research, FVC and FEV1—and their ratio, FEV1/FVC—are the most commonly assessed measures because they can be reliably obtained through standard spirometry.

Larger lung volumes are associated with greater capacity to deliver oxygen and remove carbon dioxide during physical exertion. FVC in particular is strongly linked to aerobic fitness potential and respiratory reserve during sustained exercise. Population studies have documented wide variation in spirometry measures, with some individuals having dramatically larger lung volumes than others of similar body size.

Multiple biological factors influence lung capacity. Body size—particularly height—is the strongest determinant, because taller individuals have larger thoracic cavities and proportionally larger lungs. Age influences lung volumes as lung elasticity changes over the life course. Sex differences are substantial, with males averaging higher absolute FVC and FEV1 than females of similar height. Altitude of residence during development, physical training history, and respiratory health all contribute additional variation.

The genetics behind lung capacity

Lung capacity is moderately heritable, with twin studies estimating genetic factors explain approximately 40 to 60 percent of population variation in measures such as FVC and FEV1. This genetic contribution operates through multiple pathways: the structure and size of the thoracic cavity and chest wall, the elasticity and compliance of lung tissue, the strength of respiratory muscles, and the development and maturation of airway architecture.

Large-scale GWAS have identified dozens of loci significantly associated with lung function measures. Several biologically coherent gene categories emerge from these studies, including genes involved in airway development, extracellular matrix composition, muscle function, and cell signaling.

ACTN3 encodes alpha-actinin-3, a structural protein located in the Z-disc of sarcomeres in fast-twitch (Type II) skeletal muscle fibers. Alpha-actinin-3 is required for the structural integrity and mechanical performance of fast-twitch fibers—the muscle fiber type most important for high-force, rapid contractions. The diaphragm and intercostal muscles that drive respiration include both slow- and fast-twitch fibers, and variants at the ACTN3 locus have been associated with lung function measures in large GWAS. The ACTN3 R577X variant, which results in complete absence of alpha-actinin-3 in homozygous individuals, is among the most studied functional variants in human muscle biology.

ADGRG6 (also known as GPR126) encodes an adhesion G protein-coupled receptor involved in peripheral nerve myelination and skeletal development. Research has found expression of ADGRG6 in lung tissue, and GWAS have identified this locus in analyses of spirometry phenotypes. The mechanistic connection between ADGRG6 and lung capacity may involve its role in tissue development and cellular architecture during organogenesis.

ACAN encodes aggrecan, the predominant proteoglycan of hyaline cartilage, where it interacts with hyaluronan and link proteins to form large aggregate structures that resist compression. Cartilaginous tissue is integral to the structure of the chest wall—the ribs articulate through costal cartilages, and the trachea and large airways are supported by cartilage rings. Variation in ACAN has been associated with stature and skeletal phenotypes, which intersect with the thoracic dimensions that set an upper bound on lung capacity.

The polygenic architecture of lung capacity means that many variants of individually small effect aggregate to shape baseline respiratory capacity, alongside these structural and developmental pathways.

What the research says

Research base: Robust

Large-scale GWAS of spirometry phenotypes have established a robust genetic basis for lung function variation.

Large meta-analyses of spirometry phenotypes covering hundreds of thousands of adults across diverse populations have identified over 100 genome-wide significant loci for FVC, FEV1, and FEV1/FVC ratio. These studies confirmed that lung capacity measures have a substantial polygenic genetic architecture, with associated loci enriched in pathways related to airway development, ECM biology, and musculoskeletal function (Author et al., 2023, PMID: 36641522).

Twin and sibling studies consistently estimate that genetic factors account for 40 to 60 percent of population-level variance in major spirometry measures. The remaining variance is attributable to a combination of environmental, developmental, and behavioral factors including altitude, respiratory health history, and physical training.

Subsequent large-scale analyses refined the genetic map of lung function, identifying additional loci and providing new functional annotation. Variants near genes involved in muscle structure, airway development, and ECM composition collectively explain a meaningful proportion of heritable variation in lung volume measures (Author et al., 2024, PMID: 38116116).

Polygenic scores for FVC and FEV1 show meaningful predictive correlations with measured lung function in independent validation samples, demonstrating that the aggregate genetic signal captures real biological variation.

How lung capacity affects you

A higher genetic score for lung capacity is associated with a population-level tendency toward greater FVC and FEV1 in large studies. Individuals with higher polygenic scores tend on average to have larger respiratory reserve, which may support aerobic performance potential and respiratory resilience.

It is important to recognize that lung capacity is shaped by multiple interacting factors. Physical training history—particularly endurance exercise—has documented effects on pulmonary function. Altitude of residence during developmental years is associated with larger lung volumes in adulthood. Occupational and environmental exposures including tobacco smoke, airborne pollutants, and respiratory infections influence lung function trajectories over time, often substantially.

A genetic tendency toward higher lung capacity does not guarantee strong spirometry performance, and a tendency toward lower capacity does not prevent achieving good respiratory health through training and lifestyle choices.

Working with your lung capacity profile

For individuals seeking to support lung capacity and respiratory function, the following factors have the most consistent research support:

• Endurance exercise training: Sustained aerobic training is associated with improvements in ventilatory efficiency and, over time, modest increases in measured lung volumes in previously sedentary individuals. Elite endurance athletes show substantially higher FVC compared to sedentary controls.
• Resistance training for respiratory muscles: Targeted inspiratory muscle training has shown benefits for respiratory muscle strength and endurance in research settings, with spillover effects on exercise capacity.
• Avoiding tobacco and air pollutants: Tobacco smoke is the single most potent modifier of lung function decline over time. Avoiding tobacco exposure is the most impactful modifiable factor for long-term lung function preservation.
• Maintaining healthy body weight: Higher BMI is associated with reduced FVC and FEV1 through mechanical effects on respiratory mechanics and through inflammatory pathways.

Individuals with questions about their respiratory health, lung function measures, or breathing symptoms should consult a physician or pulmonologist. Spirometry is the gold-standard assessment of lung function and provides precise, clinically actionable measurements.

Research base: Robust. This genetic association is supported by large-scale, replicated GWAS evidence from hundreds of thousands of participants. Association does not imply causation, and individual outcomes depend on many genetic and non-genetic factors. See our methodology page for how ExomeDNA evaluates evidence quality.

Related traits and genes

Lung capacity shares genetic architecture with several related respiratory and musculoskeletal phenotypes. FEV1 and the FEV1/FVC ratio are closely related spirometry measures studied in the same GWAS frameworks, with considerable overlap in associated loci.

ACTN3 connects lung capacity genetics to musculoskeletal research on fiber-type composition and athletic performance, reflecting that respiratory muscle quality is one component of the lung capacity phenotype. ADGRG6 links lung capacity to developmental biology pathways. ACAN, encoding aggrecan, bridges lung capacity genetics to skeletal and connective tissue phenotypes including height, where thoracic dimensions are a downstream determinant of lung volume.

Related traits: VO2 Max Tendency | Exercise Endurance Capacity | Aerobic Fitness | Height Tendency | Muscle Fiber Type Composition

Frequently asked questions

Is lung capacity genetic? Yes, lung capacity has a meaningful heritable component. Twin and family studies estimate that approximately 40 to 60 percent of population variation in FVC and FEV1 is attributable to genetic factors. GWAS have identified over 100 loci significantly associated with spirometry phenotypes in large meta-analyses.

What genes are associated with lung capacity? GWAS have identified many loci associated with lung function measures. Genes at associated loci include ACTN3 (encoding a structural sarcomere protein in fast-twitch muscle fibers), ADGRG6 (an adhesion GPCR expressed in lung and skeletal tissue), and ACAN (encoding aggrecan, a major ECM proteoglycan in cartilaginous tissue), among many others spanning developmental, structural, and metabolic pathways.

Can exercise improve lung capacity? Aerobic exercise training improves ventilatory efficiency and respiratory muscle endurance, and some studies show modest increases in measured lung volumes with sustained training, particularly in previously sedentary individuals. Elite endurance athletes have consistently higher FVC than sedentary controls, though the contribution of training versus genetic selection remains an area of research.

What is FVC and why is it used to measure lung capacity? FVC (forced vital capacity) is the total volume of air exhaled after a full inhalation, measured during a spirometry test. It is used as a primary measure of lung capacity in large population studies and GWAS because it is reproducible, non-invasive, and captures the functional maximum volume available for gas exchange. FEV1 captures airflow rate and is used alongside FVC to assess both capacity and airway function.

Does ACTN3 affect lung capacity? The ACTN3 gene encodes alpha-actinin-3, a structural protein in fast-twitch skeletal muscle fibers. Because respiratory muscles including the diaphragm and intercostals contain fast-twitch fibers, and because ACTN3 variants have been associated with lung function measures in large GWAS, ACTN3 is one of the biologically annotated genes in the lung capacity research landscape. The ACTN3 R577X variant is one of the most studied functional variants in human muscle biology.

Written by Scott Peeples, BS Biomedical Sciences | ExomeDNA Founder Reviewed by ExomeDNA Editorial Process

Results are not a clinical test, not a treatment recommendation, and not a substitute for professional healthcare. This page provides wellness education and is not a substitute for clinical care.

References

1. Author et al. (2023). Multi-ancestry GWAS of lung function phenotypes. PMID: 36641522.
2. Author et al. (2024). Large-scale analysis of spirometry genetics and lung capacity loci. PMID: 38116116.

Data sources: GWAS Catalog | Open Targets | ClinVar | ClinGen